Nonclassical HLA and pseudogenes in maternal-fetal tolerance and cancer. Marie Duhamel
Trends Immunol. 2025 Sep 18:S1471-4906(25)00216-9. doi: 10.1016/j.it.2025.08.006. Online ahead of print. ABSTRACT The immunological tolerance protecting the fetus from maternal rejection during pregnancy involves nonclassical human leukocyte antigen (HLA) class I molecules (HLA-G, HLA-E, HLA-F) interacting with maternal immune-inhibitory receptors. Cancers similarly exploit these molecules to evade immune detection and promote tumor progression. Pseudogenes within … Read more